Skip to content

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04592289
Acronym
REPCA
Enrollment
622
Registered
2020-10-19
Start date
2020-10-30
Completion date
2024-08-31
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

rectal cancer, bowel preparation, MBP, Oral antibiotics

Brief summary

The purpose of the study is to determine if short-term outcomes of rectal resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to rectal resections with only mechanical bowel preparation.

Detailed description

The design involves random allocation of eligible patients to full bowel preparation or only mechanical bowel preparation in 1:1 ratio. After that rectal resection is performed in both groups. Short-term outcomes are assessed in 30 day period after surgery. This is a superiority trial evaluating statistical superiority. Rate of surgical site infection is anticipated to decrease from 12% (data from local registry) to 6%. For power of 80% enrolment of 622 patients is required. The intent-to-treat principle is used for the data analysis.

Interventions

PROCEDUREFull bowel preparation

MBP+OA

PROCEDUREMechanical bowel preparation only

MBP

Sponsors

N.N. Petrov National Medical Research Center of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* histologically confirmed adenocarcinoma of the rectum or rectosigmoid junction * clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable) * indications for surgical rectal resection * ECOG status 0-2 * At least 18 years of age * Written informed consent

Exclusion criteria

* Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol * Pregnancy or breast feeding * Medical contraindications for surgical treatment * Any use of antibiotics 30 days prior to inclusion * Functioning stoma * Contraindications for use of MBP or OA drugs or their components * Indications for obstructive resection or abdominoperineal excision * Acute bowel obstruction, bleeding or perforation * Other malignancies not in remission

Design outcomes

Primary

MeasureTime frameDescription
Incisional surgical site infection (SSI) rate30 daysRate of incisional SSI in patients after rectal resections

Secondary

MeasureTime frameDescription
Intraabdominal and or pelvic abscess rate30 days
Overall morbidity30 daysRate of patients with any complications after surgery
Rate of intraoperative complicationsDuration of surgical procedure
Anastomotic leak rate30 daysRate of clinical and/or radiological anastomotic leaks
Quality of bowel preparation assessed by surgeonDay of surgeryAssessment of bowel preparation quality by surgeon (qualitative scale)
Bowel preparation complianceDay of surgeryRate of patients in experimental arm undergoing complete bowel preparation according to protocol
Surgery duration in minutesDuration of surgical procedure

Countries

Russia

Contacts

Primary ContactAleksei Karachun
dr.a.karachun@gmail.com+79219462123
Backup ContactAleksei Petrov
alexpetrov@doctor.com+79214117866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026